Company works with hospitals and surgeons to deliver high quality patient care and lower costs
BRENTWOOD, Tenn.--(BUSINESS WIRE)-- ANOVA Implant Solutions LLC, founded by longtime orthopedic and healthcare executive Walter P. Spires, Jr., is addressing the formidable challenge facing hospitals and orthopedic surgeons: provide high quality patient care and reduce costs.
“These goals are not mutually exclusive,” Spires maintains. “ANOVA developed and is executing a new business model that accomplishes both. Our approach combines efficacy and efficiency.”
Orthopedic implants have historically comprised a high percentage of the total procedure cost reimbursement. “In an industry dominated for decades by five large manufacturers, ANOVA is creating ripples in a large pool that represents billions of dollars spent annually,” Spires said.
ANOVA has a patent-pending perioperative service program and orthopedic implant price points that save hospitals hundreds to thousands of dollars per case.
ANOVA’s initial product offering is the Active Total Knee Replacement (Active TKR), developed by orthopedic manufacturer, Advanced Surgical Design & Manufacturing, Sydney, Australia. ANOVA is the exclusive provider for the Active TKR in the U.S.
Spires said, “The Active TKR represents what will become a full-suite of orthopedic implant products. We chose to begin with the Active TKR because it has proven long-term clinical success and more combined patient features and benefits than comparable total knees.”
A Successful Pilot
ANOVA began operations in 2009 with a pilot program at Centennial Medical Center, flagship hospital for HCA, one of the nation’s largest hospital systems.
Dr. Jeffrey Lawrence, of Premier Orthopedics, was the first to use the system at Centennial and instrumental in helping develop surgical procedures and processes with the Active TKR. “My experience with the Active TKR has been excellent,” said Dr. Lawrence. “It has features, technology, a wide range of sizes for women and men, range of motion, proven bearing surface wear properties, and a history of excellent clinical results. ANOVA’s business approach also allows surgeons and hospitals to manage costs more effectively.”
Earlier this year ANOVA was awarded a contract with the TriStar division of HCA. Most recently, ANOVA received the same contract status with St David’s Healthcare, part of the HCA Central & West Texas Division. ANOVA continues to expand its footprint nationally into other markets.
Backed by Seasoned Leadership
Spires began his career in orthopedics more than thirty years ago as an engineering student working at Zimmer, the largest orthopedic company. He was a member of the original management team that started Biomet, now one of the five largest orthopedic companies that dominate the industry. He was later responsible for leading global product development and research for DePuy and led the Orthopedic Business Unit team at (then) DC Wright during high growth phases. Spires arrived in Nashville eight years ago and began working on the facility and physician sides of the healthcare equation with OrthoLink, a subsidiary of United Surgical Partners International, and later HCA Physician Services.
“The combined experience on all sides of the orthopedic healthcare triangle - product, surgeon, and facility – provided me with unique understanding of the problems and potential solutions facing each stakeholder. With federal healthcare reform measures changing that environment, now more than ever, we believe there is a place in the market for ANOVA. The response to date is validation of that.”
Niles Noblitt, one of the co-founders of Biomet and past chairman of the Board, is the lead investor for ANOVA. Noblitt said, “ANOVA represents a timely and strategic opportunity to facilitate change in an industry that has historically been resistant to change in its approach to surgeons and hospitals.”
Judy Lindstrom, ANOVA board member, added, “The current healthcare environment presents many new financial challenges to providers and implant manufacturers. ANOVA provides products with years of clinical success helping patients and brings financial relief to the hospitals in the process.”
ANOVA is engaged in raising a new round of funding to support continued growth and expansion.
For more information about ANOVA, visit www.anovaimplants.com.
CONTACT:
ANOVA Implant Solutions LLC
Anne Hancock Toomey, 615-254-0575
KEYWORDS: United States North America Tennessee
INDUSTRY KEYWORDS: Surgery Health Biotechnology Hospitals Medical Devices Other Health General Health Managed Care
MEDIA:
| Logo |